NCT02936154View on ClinicalTrials.gov

Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Healthy

Interventions

DRUG

PF-06650833

DRUG

placebo

Trial Locations (1)

192-0071

P-one Clinic, Keikokai Medical Corporation, Hachioji-shi

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT02936154 - Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects | Biotech Hunter | Biotech Hunter